Drugs that contain Acyclovir

1. List of Sitavig drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8791127 EPI HLTH Mucosal bioadhesive slow release carrier for delivering active principles
Mar, 2027

(3 years from now)

US8747896 EPI HLTH Mucosal bioadhesive slow release carrier for delivering active principles
Jun, 2027

(4 years from now)

US8592434 EPI HLTH Mucoadhesive buccal tablets for the treatment of orofacial herpes
Jun, 2030

(7 years from now)

Do you want to check out SITAVIG patents from before 2022?

Market Authorisation Date: 12 April, 2013

Treatment: Treatment of herpes labialis

Dosage: TABLET;BUCCAL

More Information on Dosage

SITAVIG family patents

8

United States

7

European Union

2

Croatia

2

Canada

2

Denmark

2

Spain

2

Portugal

2

Poland

2

Japan

2

China

2

RS

1

Australia

1

Israel

IB

1

IB

1

Korea, Republic of

1

New Zealand

1

Malaysia

1

Austria

1

ME

1

Cyprus

1

Russia

1

Hong Kong

1

Germany

1

Mexico

1

Slovenia

1

Argentina

1

Brazil

1

South Africa

1

Hungary

1

Turkey

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in